211 related articles for article (PubMed ID: 38190392)
21. Gene regulation and functional alterations induced by Kaposi's sarcoma-associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells.
Sakakibara S; Pise-Masison CA; Brady JN; Tosato G
J Virol; 2009 Mar; 83(5):2140-53. PubMed ID: 19091861
[TBL] [Abstract][Full Text] [Related]
22. Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency.
Mariggiò G; Koch S; Zhang G; Weidner-Glunde M; Rückert J; Kati S; Santag S; Schulz TF
PLoS Pathog; 2017 Apr; 13(4):e1006335. PubMed ID: 28430817
[TBL] [Abstract][Full Text] [Related]
23. Kaposi's sarcoma-associated herpesvirus induces Nrf2 during de novo infection of endothelial cells to create a microenvironment conducive to infection.
Gjyshi O; Bottero V; Veettil MV; Dutta S; Singh VV; Chikoti L; Chandran B
PLoS Pathog; 2014 Oct; 10(10):e1004460. PubMed ID: 25340789
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a.
Punj V; Matta H; Schamus S; Tamewitz A; Anyang B; Chaudhary PM
Oncogene; 2010 Mar; 29(12):1835-44. PubMed ID: 20023696
[TBL] [Abstract][Full Text] [Related]
25. A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.
Sakakibara S; Espigol-Frigole G; Gasperini P; Uldrick TS; Yarchoan R; Tosato G
Oncogene; 2013 Mar; 32(10):1223-32. PubMed ID: 22525270
[TBL] [Abstract][Full Text] [Related]
26. Latent infection with Kaposi's sarcoma-associated herpesvirus enhances retrotransposition of long interspersed element-1.
Nakayama R; Ueno Y; Ueda K; Honda T
Oncogene; 2019 May; 38(22):4340-4351. PubMed ID: 30770900
[TBL] [Abstract][Full Text] [Related]
27. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces expression of the helix-loop-helix protein Id-1 in human endothelial cells.
Tang J; Gordon GM; Müller MG; Dahiya M; Foreman KE
J Virol; 2003 May; 77(10):5975-84. PubMed ID: 12719589
[TBL] [Abstract][Full Text] [Related]
28. Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily.
Amodio E; Goedert JJ; Barozzi P; Riva G; Firenze A; Bonura F; Viviano E; Romano N; Luppi M
Cancer Sci; 2011 Oct; 102(10):1769-73. PubMed ID: 21740480
[TBL] [Abstract][Full Text] [Related]
29. Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.
An FQ; Folarin HM; Compitello N; Roth J; Gerson SL; McCrae KR; Fakhari FD; Dittmer DP; Renne R
J Virol; 2006 May; 80(10):4833-46. PubMed ID: 16641275
[TBL] [Abstract][Full Text] [Related]
30. Kaposi Sarcoma Herpesvirus Induces HO-1 during De Novo Infection of Endothelial Cells via Viral miRNA-Dependent and -Independent Mechanisms.
Botto S; Totonchy JE; Gustin JK; Moses AV
mBio; 2015 Jun; 6(3):e00668. PubMed ID: 26045540
[TBL] [Abstract][Full Text] [Related]
31. vFLIP from KSHV inhibits anoikis of primary endothelial cells.
Efklidou S; Bailey R; Field N; Noursadeghi M; Collins MK
J Cell Sci; 2008 Feb; 121(Pt 4):450-7. PubMed ID: 18211958
[TBL] [Abstract][Full Text] [Related]
32. HIV-1 Tat Interacts with a Kaposi's Sarcoma-Associated Herpesvirus Reactivation-Upregulated Antiangiogenic Long Noncoding RNA, LINC00313, and Antagonizes Its Function.
Yang WS; Lin TY; Chang L; Yeh WW; Huang SC; Chen TY; Hsieh YT; Chen ST; Li WC; Pan CC; Campbell M; Yen CH; Chen YA; Chang PC
J Virol; 2020 Jan; 94(3):. PubMed ID: 31723026
[TBL] [Abstract][Full Text] [Related]
33. p53 inhibition by the LANA protein of KSHV protects against cell death.
Friborg J; Kong W; Hottiger MO; Nabel GJ
Nature; 1999 Dec 23-30; 402(6764):889-94. PubMed ID: 10622254
[TBL] [Abstract][Full Text] [Related]
34. Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma.
Liu R; Gong M; Li X; Zhou Y; Gao W; Tulpule A; Chaudhary PM; Jung J; Gill PS
Blood; 2010 Jul; 116(2):297-305. PubMed ID: 20442363
[TBL] [Abstract][Full Text] [Related]
35. Endothelial cell- and lymphocyte-based in vitro systems for understanding KSHV biology.
McAllister SC; Moses AV
Curr Top Microbiol Immunol; 2007; 312():211-44. PubMed ID: 17089799
[TBL] [Abstract][Full Text] [Related]
36. KSHV hijacks FoxO1 to promote cell proliferation and cellular transformation by antagonizing oxidative stress.
Li T; Gao SJ
J Med Virol; 2023 Mar; 95(3):e28676. PubMed ID: 36929740
[TBL] [Abstract][Full Text] [Related]
37. Deletion of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein, vFLIP, from the viral genome compromises the activation of STAT1-responsive cellular genes and spindle cell formation in endothelial cells.
Alkharsah KR; Singh VV; Bosco R; Santag S; Grundhoff A; Konrad A; Stürzl M; Wirth D; Dittrich-Breiholz O; Kracht M; Schulz TF
J Virol; 2011 Oct; 85(19):10375-88. PubMed ID: 21795355
[TBL] [Abstract][Full Text] [Related]
38. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions.
Paudel N; Sadagopan S; Chakraborty S; Sarek G; Ojala PM; Chandran B
J Virol; 2012 Jun; 86(11):5974-91. PubMed ID: 22438557
[TBL] [Abstract][Full Text] [Related]
39. Transcriptomic analysis of KSHV-infected primary oral fibroblasts: The role of interferon-induced genes in the latency of oncogenic virus.
Dai L; Bai L; Lin Z; Qiao J; Yang L; Flemington EK; Zabaleta J; Qin Z
Oncotarget; 2016 Jul; 7(30):47052-47060. PubMed ID: 27363016
[TBL] [Abstract][Full Text] [Related]
40. CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation.
Hunte R; Alonso P; Thomas R; Bazile CA; Ramos JC; van der Weyden L; Dominguez-Bendala J; Khan WN; Shembade N
PLoS Pathog; 2018 Apr; 14(4):e1006968. PubMed ID: 29698475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]